NR4A1 and sarcopenia: As Nur77 is selectively expressed in type 2 glycolytic myofibers, analysis of muscle Nur77 expression in mouse models of DMD and sarcopenia will help determine whether Nur77 is a viable target in the management of muscle wasting in these conditions.